Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants.

Clinical trial NCT06514157 · COMPLETED

Trial details

NCT number: NCT06514157
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2024-08-19
Primary completion: 2024-09-09
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.